David M Mott's Net Worth

$2.21 Billion

Estimate Recalculated Feb 21, 2024 07:58PM EST

Who is David M Mott?

David M Mott has an estimated net worth of $2.21 Billion. This is based on reported shares across multiple companies, which include PhaseBio Pharmaceuticals Inc, Ra Pharmaceuticals, Inc., Cloudflare, Inc., RHYTHM PHARMACEUTICALS, INC., TESARO, Inc., Dermira, Inc., Cascadian Therapeutics, Inc., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Mersana Therapeutics, Inc., MULESOFT, INC, Elastic N.V., NOVAVAX INC, Oyster Point Pharma, Inc., AVEO PHARMACEUTICALS INC, Sprout Social, Inc., APPIAN CORP, Clovis Oncology, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, BOX INC, Nightstar Therapeutics plc, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., GENOCEA BIOSCIENCES, INC., Millendo Therapeutics, Inc., ARDELYX, INC., Galera Therapeutics, Inc., Trevi Therapeutics, Inc., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., SYNLOGIC, INC., Epizyme, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Roka BioScience, Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., IMARA Inc., Marker Therapeutics, Inc., Omthera Pharmaceuticals, Inc., Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Casper Sleep Inc., INTERLEUKIN GENETICS INC, and MEDIMMUNE INC /DE.

SEC CIK

David M Mott's CIK is 0001219871

Past Insider Trading and Trends

2018 was David M Mott's most active year for acquiring shares with 85 total transactions. David M Mott's most active month to acquire stocks was the month of May. 2019 was David M Mott's most active year for disposing of shares, totalling 33 transactions. David M Mott's most active month to dispose stocks was the month of May. 2016 saw David M Mott paying a total of $94,800,960.53 for 55,630,624 shares, this is the most they've acquired in one year. In 2019 David M Mott cashed out on 147,782,355 shares for a total of $955,445,377.38, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cloudflare, Inc. (NET) Snapshot price: $83.03

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.06M
4.06M
Sep 17
Form 3
0
0
No matching records found

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
6.64M
$5.00
6.64M
Oct 22
Form 3
0
0
No matching records found

Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1708

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.36M
$12.00
4.36M
Nov 12
Form 3
0
0
No matching records found

Ra Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+11.75%
645.16K
$15.50
$9,999,995.50
6.14M
Dec 14
Form 4
+57.31%
2M
$6.00
$12,000,000.00
5.49M
Feb 16
Form 4
3.49M
$11.76
-$5,655.00
3.49M
Oct 31
Form 3
0
0
No matching records found

Oyster Point Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,737.54%
5.6M
$16.00
5.93M
Nov 4
Form 3
0
0
No matching records found